GENSIGHT BIOLOGICS Stock Falls By 27% In The Last 21 Sessions
(VIANEWS) – Shares of GENSIGHT BIOLOGICS (CAC 40: SIGHT.PA) slid by a staggering 27.19% in 21 sessions from €3.01 to €2.19 at 15:01 EST on Tuesday, following the last session’s downward trend. CAC 40 is falling 0.11% to €7,070.39, following the last session’s upward trend. About GENSIGHT BIOLOGICS GenSight Biologics S.A., a clinical-stage biotechnology company,…